Investec PLC/ GB00B17BBQ50 /
2024-10-09 5:29:50 PM | Chg. +2.50 | Volume | Bid5:30:00 PM | Ask5:30:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
574.00GBX | +0.44% | 152,576 Turnover(GBP): 871,152.1250 |
-Bid Size: - | -Ask Size: - | 4.9 bill.GBP | - | - |
GlobeNewswire
07-22
C4X Discovery Holdings Limited announces progress on immuno-inflammation programmes and appointment ...
GlobeNewswire
07-11
Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansio...
GlobeNewswire
06-28
Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determinatio...
GlobeNewswire
05-09
Renalytix to Report Financial Results for Third Quarter Fiscal Year 2024 on May 15
GlobeNewswire
03-14
KidneyIntelX™ included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease (CKD)
GlobeNewswire
02-09
Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Confer...
GlobeNewswire
01-16
Hydreight to Participate in the Maxim Group Healthcare IT Conference January 24 – 25, 2024
GlobeNewswire
01-10
New published data demonstrates KidneyIntelX™ has broad implications for winning war on chronic kidn...
GlobeNewswire
2023-12-20
SJI and Captona Announce Construction of one of the Largest Food Waste-to-RNG Facilities in the US
GlobeNewswire
2023-12-18
Tingo Group Wins ‘Outstanding New Entry’ at The SERAS Africa CSR / Sustainability Awards
GlobeNewswire
2023-12-05
Tingo Group’s Commitment to Corporate Social Responsibility and Sustainability Recognized with SERAS...
GlobeNewswire
2023-11-07
Renalytix to Report Financial Results for First Quarter Fiscal Year 2024 on November 14
GlobeNewswire
2023-10-06
US Patent Office Allows Patent Claims for Intellectual Property Exclusively Licensed to Renalytix
GlobeNewswire
2023-09-25
Renalytix to Report Financial Results for Fourth Quarter and Full Year Fiscal 2023 on September 28
GlobeNewswire
2023-09-06
Institutional Investor Launches 2023 Developed Europe, 2023 UK Small & Midcap and 2023 Emerging Emea...
GlobeNewswire
2022-03-25
Renalytix to Report Second Quarter and First Half Fiscal Year 2022 Financial Results on March 31